Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Human Vaccines & Immunotherapeutics

• Publication date

  2017-10-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1080/21645515.2017.1303582PMID 28362548PMCID PMC5703406
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TCR Sequencing Can Identify and Track Glioma-Infiltrating T Cells after DC Vaccination

  2016cited by this paper
• Recent advances and future of immunotherapy for glioblastoma

  2016cited by this paper
• Dendritic cells loading autologous tumor lysate promote tumor angiogenesis

  2016cited by this paper
• Active dendritic cell immunotherapy for glioblastoma: Current status and challenges

  2015cited by this paper
• Biomarkers for glioma immunotherapy: the next generation

  2015cited by this paper
• Enhanced immunosuppression by therapy‐exposed glioblastoma multiforme tumor cells

  2015cited by this paper
• Detection of Human Cytomegalovirus in Different Histopathological Types of Glioma in Iraqi Patients

  2015cited by this paper
• Human Cytomegalovirus Tegument Protein pp65 Is Detected in All Intra- and Extra-Axial Brain Tumours Independent of the Tumour Type or Grade

  2014cited by this paper
• Cytokine responsiveness of CD8+ T cells is a reproducible biomarker for the clinical efficacy of dendritic cell vaccination in glioblastoma patients

  2014cited by this paper
• Immature mesenchymal stem cell-like pericytes as mediators of immunosuppression in human malignant glioma.

  2013cited by this paper
• Dendritic cell immunotherapy

  2013cited by this paper
• A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma.

  2011influential reference
• Gene Expression Profile Correlates with T-Cell Infiltration and Relative Survival in Glioblastoma Patients Vaccinated with Dendritic Cell Immunotherapy

  2010influential reference
• CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival.

  2010cited by this paper
• Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy.

  2008influential reference
• T-cell apoptosis in human glioblastoma multiforme: implications for immunotherapy.

  2006cited by this paper
• T cells traffic from brain to cervical lymph nodes via the cribroid plate and the nasal mucosa

  2006cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial.

  2005cited by this paper
• Dendritic Cell Vaccination in Glioblastoma Patients Induces Systemic and Intracranial T-cell Responses Modulated by the Local Central Nervous System Tumor Microenvironment

  2005cited by this paper
• Vaccination with Tumor Lysate-Pulsed Dendritic Cells Elicits Antigen-Specific, Cytotoxic T-Cells in Patients with Malignant Glioma

  2004influential reference
• Antitumor vaccination of patients with glioblastoma multiforme: a pilot study to assess feasibility, safety, and clinical benefit.

  2004cited by this paper
• Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

  2004cited by this paper
• 254. Vaccination of Recurrent Glioma Patients with Tumour Lysate-Pulsed Dendritic Cells Elicits Immune Responses: Results of a Clinical Phase I/II Trial

  2004cited by this paper
• The mononuclear cell infiltrate compared with survival in high-grade astrocytomas

  2004cited by this paper
• MART-1 adenovirus-transduced dendritic cell immunization in a murine model of metastatic central nervous system tumor

  2003cited by this paper
• Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

  2003cited by this paper
• Vaccination of recurrent glioma patients with tumour lysate-pulsed dendritic cells elicits immune responses: results of a clinical phase I/II trial

  2003cited by this paper
• Tumor immunity within the central nervous system stimulated by recombinant Listeria monocytogenes vaccination.

  2002cited by this paper
• A fresh look at tumor immunosurveillance and immunotherapy

  2001cited by this paper
• Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.

  2001cited by this paper
• Regression of human metastatic renal cell carcinoma after vaccination with tumor cell–dendritic cell hybrids

  2000cited by this paper
• Treatment of intracranial gliomas with bone marrow-derived dendritic cells pulsed with tumor antigens.

  1999cited by this paper
• Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cells

  1998cited by this paper
• CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.

  1998cited by this paper
• Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

  1998cited by this paper
• Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response.

  1996cited by this paper
• Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells

  1996cited by this paper
• Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

  1996cited by this paper
• Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system.

  1996cited by this paper
• Cure of established, intracerebral rat gliomas induced by therapeutic immunizations with tumor cells and purified APC or adjuvant IFN-gamma treatment.

  1996cited by this paper
• Model predicting survival in stage I melanoma based on tumor progression.

  1989cited by this paper
• Prognostic value of round cell (lymphocyte) infiltration in malignant gliomas.

  1985cited by this paper
• Mononuclear infiltrates in human intracranial tumors as a prognostic factor. Influence of preoperative steroid treatment. I. Glioblastoma.

  1984cited by this paper
• Analysis of Some Factors Effecting Survival in Malignant Gliomas

  1979cited by this paper
• Relationship of lymphocyte invasion and survival of brain tumor patients

  1978cited by this paper
• Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases.

  1978cited by this paper
• Tissue T and B cell infiltration of primary and metastatic cancer.

  1976cited by this paper
• Possible host resistance in carcinoma of the breast: a histological study.

  1968cited by this paper
• FACTORS WHICH INFLUENCE LONGEVITY IN CANCER

  1922cited by this paper
• LONGEVITY IN CANCER: A STUDY OF 293 CASES.

  1922cited by this paper
• An experimental investigation of infective sarcoma of the dog, with a consideration of its relationship to cancer

  year unknowncited by this paper

• Therapeutic effects of a new selenium-sorafenib nanocomplex in liver and tumor in a TAA-induced HCC model.

  2025cites this paper
• Integrated multi-omics analysis reveals diagnostic biomarkers and therapeutic targets for systemic lupus erythematosus

  2025cites this paper
• TFPI and ROCK1 serve as the key genes in the vasculogenic mimicry-related prognostic nomogram for glioblastoma.

  2025cites this paper
• Survival profiles and associated factors for overall and cancer specific survival in patients with chondroblast and fibroblastic osteosarcoma

  2025cites this paper
• Multidimensional analysis suggests that ZNF433 is a promising biomarker for the diagnosis and prognosis of human cancers

  2025cites this paper
• Oligodendroglioma: Advances in Molecular Mechanisms and Immunotherapeutic Strategies

  2025cites this paper
• ADCYAP1 as a pan-solid cancer biomarker: predictor of immunotherapy efficacy in bladder cancer and prognostic potential across solid tumors

  2025cites this paper
• SECTM1 acts as an immune-related biomarker of poor prognosis and promotes cancer progression by modulating M2 macrophage polarization in esophageal squamous cell carcinoma

  2025cites this paper
• Construction and validation of a prognostic signature using WGCNA-identified key genes in osteosarcoma for treatment evaluation

  2025cites this paper
• A seven-LncRNA signature for prognosis prediction of patients with lung squamous cell carcinoma through tumor immune escape

  2025cites this paper
• Cuproptosis-related gene DLD expression correlates with the prognosis and tumor immune microenvironment in clear cell renal cell carcinoma

  2025cites this paper
• Banxia-Shengjiang drug pair inhibits gastric cancer development and progression by improving body immunity

  2024cites this paper
• REXO2 up-regulation is positively correlated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma.

  2024cites this paper
• TRP-2 / gp100 DNA vaccine and PD-1 checkpoint blockade combination for the treatment of intracranial tumors

  2024cites this paper
• Understanding immune microenvironment alterations in the brain to improve the diagnosis and treatment of diverse brain diseases

  2024cites this paper
• Exploration of functional relations among differentially co-expressed genes identifies regulators in glioblastoma

  2024cites this paper
• Biomolecules to Biomarkers? U87MG Marker Evaluation on the Path towards Glioblastoma Multiforme Pathogenesis

  2024cites this paper
• Neuroinflammation in Glioblastoma: The Role of the Microenvironment in Tumour Progression.

  2024cites this paper
• Immune cells: potential carriers or agents for drug delivery to the central nervous system

  2024cites this paper
• Prognostic and Therapeutic Implications of Cell Division Cycle 20 Homolog in Breast Cancer

  2024cites this paper
• SP140 inhibitor suppressing TRIM22 expression regulates glioma progress through PI3K/AKT signaling pathway

  2024cites this paper
• Bioinformatics Analysis Reveals Candidate Biomarkers Served As Dendritic Cell-based Lung Squamous CellCarcinoma (LUSC) Treatment

  2024cites this paper
• EXT1 as an Independent Prognostic Biomarker in Breast Cancer: Its Correlation with Immune Infiltration and Clinicopathological Parameters

  2024cites this paper
• Development and validation of disulfidptosis-related genes signature for patients with glioma

  2024cites this paper
• EDNRA regulates the tumour immune environment and predicts the efficacy and prognosis of cancer immunotherapy

  2024cites this paper
• Single-cell and machine learning approaches uncover intrinsic immune-evasion genes in the prognosis of hepatocellular carcinoma

  2024cites this paper
• Batroxase promotes the effect of NK cell adoptive therapy on lung cancer by enhancing immune cell infiltration.

  2024cites this paper
• Expression and significant roles of the long non-coding RNA CASC19/miR-491-5p/HMGA2 axis in the development of gastric cancer

  2024cites this paper
• A novel oncolytic virus-based biomarker participates in prognosis and tumor immune infiltration of glioma

  2023cites this paper
• A programmed cell death-related model based on machine learning for predicting prognosis and immunotherapy responses in patients with lung adenocarcinoma

  2023cites this paper
• Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer

  2023cites this paper
• A systematic framework for identifying prognostic necroptosis-related lncRNAs and verification of lncRNA CRNDE/miR-23b-3p/IDH1 regulatory axis in glioma

  2023cites this paper
• Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis

  2023cites this paper
• PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma

  2023cites this paper
• The PTEN-associated immune prognostic signature reveals the landscape of the tumor microenvironment in glioblastoma.

  2023cites this paper
• Exosome-Associated Gene Signature for Predicting the Prognosis of Ovarian Cancer Patients

  2023cites this paper
• Solute Carrier Family 7 Member 11 (SLC7A11) is a Potential Prognostic Biomarker in Uterine Corpus Endometrial Carcinoma

  2023cites this paper
• Establishment of Ferroptosis-Related Key Gene Signature and Its Validation in Compression-Induced Intervertebral Disc Degeneration Rats

  2023cites this paper
• Progress in phase III clinical trials of molecular targeted therapy and immunotherapy for glioblastoma

  2023cites this paper
• Phosducin-like 3 is a novel prognostic and onco-immunological biomarker in glioma: A multi-omics analysis with experimental verification

  2023cites this paper
• Subtype classification based on t cell proliferation-related regulator genes and risk model for predicting outcomes of lung adenocarcinoma

  2023cites this paper
• Oncogenic role of copper‑induced cell death‑associated protein DLD in human cancer: A pan‑cancer analysis and experimental verification

  2023cites this paper
• Machine learning-based prediction of diagnostic markers for Graves’ orbitopathy

  2023cites this paper
• High expression of RNF31 is associated with tumor immune cell infiltration and leads to poor prognosis in liver hepatocellular carcinoma

  2023cites this paper
• Development and validation of an immune infiltration/tumor proliferation-related Notch3 nomogram for predicting survival in patients with primary glioblastoma

  2023cites this paper
• Lymphocyte infiltration and antitumoral effect promoted by cytotoxic inflammatory proteins formulated as self-assembling, protein-only nanoparticles.

  2023cites this paper
• The value of basement membrane-associated genes in the prognosis and immune regulation of glioma

  2023cites this paper
• Identification of natural killer cell-related characteristics to predict the clinical prognosis and immune microenvironment of patients with low-grade glioma

  2023cites this paper
• Development and Validation of CXCR4 Nomogram-Based Immune Infiltration/Tumor Inflammation in Primary Glioblastoma

  2023cites this paper
• Integrative analysis identifies AKAP8L as an immunological and prognostic biomarker of pan-cancer

  2023cites this paper
• SU4312 Represses Glioma Progression by Inhibiting YAP and Inducing Sensitization to the Effect of Temozolomide

  2022cites this paper
• Effects of ESCO2 or its methylation on the prognosis, clinical characteristics, immune microenvironment, and pathogenesis of low-grade glioma.

  2022cites this paper
• Pan-Cancer Analysis Revealed SRSF9 as a New Biomarker for Prognosis and Immunotherapy

  2022cites this paper
• BET Bromodomain Inhibitors OTX015

  2022cites this paper
• Expression profile and prognostic values of Chromobox family members in human glioblastoma

  2022cites this paper
• Diverse Chromobox Family Members: Potential Prognostic Biomarkers and Therapeutic Targets in Head and Neck Squamous Cell Carcinoma

  2022cites this paper
• NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma

  2022cites this paper
• A pan-cancer analysis on the carcinogenic effect of human adenomatous polyposis coli

  2022cites this paper
• Comprehensive Analysis of ANLN in Human Tumors: A Prognostic Biomarker Associated with Cancer Immunity

  2022cites this paper
• Molecular mechanism by which CDCP1 promotes proneural-mesenchymal transformation in primary glioblastoma

  2022cites this paper
• Therapeutic Options in Neuro-Oncology

  2022cites this paper
• hsa-miR-9-5p-Mediated TSPAN9 Downregulation Is Positively Related to Both Poor Hepatocellular Carcinoma Prognosis and the Tumor Immune Infiltration

  2022cites this paper
• Weighted Gene Co-Expression Network Analysis (WGCNA) Reveals the Functions of Syndecan-1 to Regulate Immune Infiltration by Influenced T Cells in Glioma

  2022cites this paper
• Transcriptome Analysis and Single-Cell Sequencing Analysis Constructed the Ubiquitination-Related Signature in Glioma and Identified USP4 as a Novel Biomarker

  2022cites this paper
• Advances in Immune Microenvironment and Immunotherapy of Isocitrate Dehydrogenase Mutated Glioma

  2022cites this paper
• Tripartite motif-containing 25 facilitates immunosuppression and inhibits apoptosis of glioma via activating NF-κB

  2022cites this paper
• Long-Noncoding RNA MANCR is Associated With Head and Neck Squamous Cell Carcinoma Malignant Development and Immune Infiltration

  2022cites this paper
• Characterization of the immune cell infiltration landscape in myxofibrosarcoma to aid immunotherapy

  2022influential citation
• A novel cuproptosis-related prognostic lncRNA signature and lncRNA MIR31HG/miR-193a-3p/TNFRSF21 regulatory axis in lung adenocarcinoma

  2022cites this paper
• ABCD3 is a prognostic biomarker for glioma and associated with immune infiltration: A study based on oncolysis of gliomas

  2022cites this paper
• Multiple roles of apolipoprotein B mRNA editing enzyme catalytic subunit 3B (APOBEC3B) in human tumors: a pan-cancer analysis

  2022cites this paper
• A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma

  2022cites this paper
• The comprehensive expression and functional analysis of m6A modification “readers” in hepatocellular carcinoma

  2022cites this paper
• Identification of OTUD6B as a new biomarker for prognosis and immunotherapy by pan-cancer analysis

  2022cites this paper
• Identification of potential targets of the curcumin analog CCA-1.1 for glioblastoma treatment : integrated computational analysis and in vitro study

  2022cites this paper
• A specific immune signature for predicting the prognosis of glioma patients with IDH1-mutation and guiding immune checkpoint blockade therapy

  2022cites this paper
• APOL4, a Novel Immune-Related Prognostic Biomarker for Glioma

  2022cites this paper
• TREM2 Is a Prognostic Biomarker and Correlated with an Immunosuppressive Microenvironment in Thyroid Cancer

  2022cites this paper
• Dendritic cell vaccines improve the glioma microenvironment: Influence, challenges, and future directions

  2022cites this paper
• Study of epirubicin sustained–release chemoablation in tumor suppression and tumor microenvironment remodeling

  2022cites this paper
• The Clinical Significance and Potential Molecular Mechanism of Upregulated CDC28 Protein Kinase Regulatory Subunit 1B in Osteosarcoma

  2021cites this paper
• High expression of SETDB1 mediated by miR-29a-3p associates with poor prognosis and immune invasion in breast invasive carcinoma

  2021cites this paper
• Galectin-9/TIM-3 as a Key Regulator of Immune Response in Gliomas With Chromosome 1p/19q Codeletion

  2021cites this paper
• AEBP1 as a potential immune-related prognostic biomarker in glioblastoma: a bioinformatic analyses

  2021cites this paper
• Screening and Prognostic Analysis of Immune-Related Genes in Pancreatic Cancer

  2021cites this paper
• Identification of Prognostic Metabolism-Related Genes in Clear Cell Renal Cell Carcinoma

  2021cites this paper
• Comprehensive Analysis of Immune-Related Metabolic Genes in Lung Adenocarcinoma

  2021cites this paper
• Aggresome–Autophagy Associated Gene HDAC6 Is a Potential Biomarker in Pan-Cancer, Especially in Colon Adenocarcinoma

  2021cites this paper
• Prognostic Impact of MITD1 and Associates With Immune Infiltration in Kidney Renal Clear Cell Carcinoma

  2021cites this paper
• CircTMC5 promotes gastric cancer progression and metastasis by targeting miR-361-3p/RABL6

  2021cites this paper
• A comprehensive analysis of immune infiltration in the tumor microenvironment of osteosarcoma

  2021cites this paper
• Integrative Analysis of DNA Methylation and Transcriptome Identifies a Predictive Epigenetic Signature Associated With Immune Infiltration in Gliomas

  2021cites this paper
• Identified lung adenocarcinoma metabolic phenotypes and their association with tumor immune microenvironment

  2021cites this paper
• Development of a prognostic index based on immunogenomic landscape analysis in glioma

  2021cites this paper
• Development of a prognostic index of colon adenocarcinoma based on immunogenomic landscape analysis

  2020cites this paper
• Expression patterns and the prognostic value of the EMILIN/Multimerin family members in low-grade glioma

  2020cites this paper
• A Four-Immune Gene Prognostic Risk Model for Colorectal Adenocarcinoma Based on the TCGA and Immport Data Sets

  2020cites this paper
• Investigation of Candidate Genes and Mechanism Associated with Immune Cell during the Progression of Glioblastoma based on Bioinformatics

  2020cites this paper
• Identification of a Gene Set Correlated With Immune Status in Ovarian Cancer by Transcriptome-Wide Data Mining

  2020cites this paper
• Tumor‐associated macrophages as treatment targets in glioma

  2020cites this paper